Related Experiment Video

Updated: May 24, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis

Tony Tiganis1

  • 1Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia. tony.tiganis@monash.edu

The FEBS Journal
|March 13, 2012
PubMed

Insights

Inhibiting protein tyrosine phosphatases (PTPs), specifically PTP1B and TCPTP, can improve glucose homeostasis. These phosphatases regulate insulin receptor signaling, offering potential drug targets for type 2 diabetes.

Area of Science:

  • Biochemistry
  • Cellular Biology
  • Endocrinology

Background:

  • Insulin resistance is central to type 2 diabetes, involving impaired insulin receptor (IR) signaling.
  • Protein tyrosine phosphatases (PTPs) antagonize IR signaling, making them potential therapeutic targets.

Purpose of the Study:

  • To review the roles of PTP1B and TCPTP in regulating IR signaling and glucose homeostasis.
  • To discuss the potential of PTP1B and TCPTP as drug targets for type 2 diabetes.

Main Methods:

  • Review of existing literature on PTP1B, TCPTP, IR signaling, and glucose homeostasis.
  • Analysis of studies involving PTP1B-deficient mice in models of insulin resistance.

Main Results:

  • PTP1B dephosphorylates and attenuates IR signaling in liver and muscle.
  • PTP1B-deficient mice show improved glucose homeostasis in diabetes models.
  • TCPTP, highly similar to PTP1B, also regulates IR signaling.
  • PTP1B and TCPTP act specifically and nonredundantly to control insulin signaling.

Conclusions:

  • PTP1B and TCPTP play crucial, distinct roles in insulin signaling and glucose metabolism.
  • Targeting PTP1B and TCPTP may enhance IR phosphorylation and insulin sensitivity for type 2 diabetes treatment.

More Related Videos

Development and Application of Rapamycin-regulated Tyrosine Phosphatases06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors10:17

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

Published on: April 29, 2022

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...